- Conditions
- Bone Mineral Density
- Interventions
- 91-day Levonorgestrel Oral Contraceptive, 28-day Levonorgestrel Oral Contraceptive
- Drug
- Lead sponsor
- Duramed Research
- Industry
- Eligibility
- 12 Years to 18 Years · Female only
- Enrollment
- 1,361 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2012
- U.S. locations
- 46
- States / cities
- Phoenix, Arizona • Tucson, Arizona • North Little Rock, Arkansas + 39 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–4
of 4
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Dysmenorrhea
- Interventions
- levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets, levonorgestrel/EE 0.15/0.03 mg tablets and placebo
- Drug
- Lead sponsor
- Duramed Research
- Industry
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 97 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 18
- States / cities
- Huntsville, Alabama • Phoenix, Arizona • San Diego, California + 14 more
- Conditions
- Contraception
- Interventions
- Levonorgestrel/EE 0.15/0.03 mg and EE 0.01 mg tablets
- Drug
- Lead sponsor
- Duramed Research
- Industry
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 320 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2003 – 2006
- U.S. locations
- 11
- States / cities
- Tucson, Arizona • Washington D.C., District of Columbia • Lincoln, Nebraska + 8 more
- Conditions
- Dysmenorrhea
- Interventions
- levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets, Placebo tablet
- Drug
- Lead sponsor
- Duramed Research
- Industry
- Eligibility
- Up to 17 Years · Female only
- Enrollment
- 95 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2008
- U.S. locations
- 13
- States / cities
- Denver, Colorado • Decatur, Georgia • Louisville, Kentucky + 10 more